Global ConSeptS – Consultancy
Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Enhancing Virtual Training: Role-Playing in Meetings – Impetus InSite Tips #7
Videos and Podcasts | May 16, 2024 | Impetus Digital
Explore the effectiveness of role-playing in virtual meetings with our seventh tip. Learn how assigning roles like "influencer" or "educator" can deepen understanding and enhance communication skills among participants.
Exploring medical education and why it relies on real-world research
White Papers and Resources | May 16, 2024 | Onyx Health
Onyx Health's Head of Medical Education, Sarah Seilly, explains our approach to MedEd and the benefits of tailoring your own
Pioneering Paths: Women Leadership in Rare Disease
Press Releases | May 15, 2024 | Medscape Education
Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...
Boosting Engagement with Fun: Asynchronous Touchpoints – Impetus InSite Tips for Optimizing Asynchronous Virtual Meetings
Videos and Podcasts | May 9, 2024 | Impetus Digital
Unlock the secret to keeping participants engaged in longer asynchronous touchpoints with our sixth tip. Learn how integrating elements of fun can refresh focus and enhance interaction in virtual settings.
Beyond the AI anxiety: The impact of human intuition
White Papers and Resources | May 7, 2024 | Mednet
Explore the ways we're adapting to work with AI, not against it
NHS primary care panel – the GP Contract and Operational Planning Guidance – Live Webinar
Press Releases | May 7, 2024 | Petauri Evidence
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...
Free Live Webinar – Uniting Communities for Rare Disease Clinical Trial Success
Press Releases | May 3, 2024 | Innovative Trials
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
Navigating the rapidly changing oncology treatment landscape: how digital tools can help
White Papers and Resources | May 2, 2024 | Impetus Digital
With rapid growth comes growing pains...
TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH
Press Releases | May 2, 2024 | Medscape Education
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...
Hope in cancer therapy
Press Releases | May 1, 2024 | Springer Nature
The future looks hopeful as second-generation radiopharmaceuticals venture into uncharted territories.